Expanded amphetamines and interferences including TFMPP by MSD on a ZB-Drug1

Expanded amphetamines and interferences including TFMPP by MSD on a ZB-Drug1
GC Conditions
Column

Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea

Part No

7CD-G023-08

Phase Name

ZB-Drug-1

Injection

Split 10:1 @ 260°C

Carrier Gas

Constant Flow Helium, 0.5 mL/min

Detection

Mass Selective (MSD) @ (320°C)

Detection Info
Sample Notes

Analytes are 20ppm derivatized with HFBA Sim ions: (Quant ion*) D11-Amphetamine (*244,128): Amphetamine (*240,118,117): D14-Methamphetamine (*261,213): Methamphetamine (*254,210,118): D5-MDA (*167,380,244): MDA (*162,375,240): D5-MDMA (*258,213,164): MDMA (*254,210,389): D5-MDEA (*273,241,408): MDEA (*268,240,403) Note: Amphetamine-d11 does not share ions with coeluting interferences.

Order Items Used in This Application

Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
7CD-G023-08

Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea

View Product

  • 1. Norephedrine
  • 2. Norpseudoephedrine
  • 3. Phentermine
  • 4. Amphetamine-d11
  • 5. Amphetamine
  • 6. Ephedrine
  • 7. Methamphetamine-d14
  • 8. Methamphetamine
  • 9. Pseudoephedrine
  • 10. MDA-d5
  • 11. MDA
  • 12. MDMA-d5
  • 13. MDMA
  • 14. TFMPP
  • 15. MDEA-d5
  • 16. MDEA
Similar Applications

No Similar applications found.